Zacks Investment Research on MSN
Pacific Biosciences of California (PACB) stock declines while market improves: Some information for investors
Pacific Biosciences of California (PACB) ended the recent trading session at $1.71, demonstrating a -1.16% change from the preceding day's closing price. The stock trailed the S&P 500, which ...
Zacks Investment Research on MSN
PacBio & Lucid Genomics partner to boost data analysis, stock up
PacBio PACB recently announced a compatibility collaboration with Lucid Genomics, bringing the latter into its Compatible ...
Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, recently announced that its HiFi whole-genome sequencing technology has been adopted as a first-line approach in a major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results